Opioid-induced constipation: a multidisciplinary problem

Professor Andrew Davies, President of MASCC (Multinational Association of Supportive Care in Cancer) explains the difference between OIC and other types of constipation, presenting quantitative data from the StOIC 1 study, a large study involving cancer patients in the UK, to highlight its impact on patients’ quality of life.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email: PVUK@grunenthalmeds.com